University of British Columbia
2405 Wesbrook Mall
Vancouver
British Columbia
V6T 1Z3
Canada
Tel: 6048221794
Email: pharmsci.hr@ubc.ca
8 articles with University of British Columbia
-
Eyam Acquires Option for Novel Antibody Biologic Therapeutics for the Treatment of Leukemia and Lymphoma
9/27/2022
Eyam Vaccines and Immunotherapeutics (Eyam), has announced the acquisition of a new Option to license the patents related to an antibody biologic cancer therapeutic from the University of British Columbia (UBC).
-
Eyam Vaccines And Immunotherapeutics Embarks On New Licensing Agreement For Creating Innovative Vaccine Technologies
8/3/2022
Eyam Vaccines and Immunotherapeutics (Eyam), has announced a new licensing agreement for innovative vaccine technologies from the University of British Columbia (UBC), and the James Hutton Institute (JHI).
-
Research scientists have found that a colony-stimulating factor 1 receptor inhibitor may also be a potential treatment for Duchenne muscular dystrophy.
-
Recent research supports a link between vitamin D deficiency and severe COVID-19. Here’s a look.
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
Repeat: Core One Labs Vocan Biotechnologies Enters into Collaborative Research Agreement with UBC
4/26/2021
Core One Labs Inc., is pleased to announce its wholly owned subsidiary Vocan, has entered into a Collaborative Research Agreement with the University of British Columbia.
-
Core One Labs Vocan Biotechnologies Enters into Collaborative Research Agreement with UBC
4/24/2021
Core One Labs Inc., is pleased to announce its wholly owned subsidiary Vocan, has entered into a Collaborative Research Agreement with the University of British Columbia.
-
MYND Life Sciences Inc. Announces Collaborative Research Agreement with the University of British Columbia on Major Depressive Disorder
2/2/2021
MYND Life Sciences Inc. a life sciences company focused on novel psychedelic drug development and pharmaceuticals, is pleased to announce it has signed a Collaborative Research Agreement with the University of British Columbia focussing on Major Depressive Disorder, often referred to as depression.